Cargando…
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials
AIMS: The incidence and predictors of stroke in patients with heart failure and preserved ejection fraction (HF-PEF), but without atrial fibrillation (AF), are unknown. We described the incidence of stroke in HF-PEF patients with and without AF and predictors of stroke in those without AF. METHODS A...
Autores principales: | Abdul-Rahim, Azmil H., Perez, Ana-Cristina, MacIsaac, Rachael L., Jhund, Pardeep S., Claggett, Brian L., Carson, Peter E., Komajda, Michel, McKelvie, Robert S., Zile, Michael R., Swedberg, Karl, Yusuf, Salim, Pfeffer, Marc A., Solomon, Scott D., Lip, Gregory Y.H., Lees, Kennedy R., McMurray, John J.V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460584/ https://www.ncbi.nlm.nih.gov/pubmed/28426886 http://dx.doi.org/10.1093/eurheartj/ehw509 |
Ejemplares similares
-
Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction
por: Shen, Li, et al.
Publicado: (2020) -
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction
por: Shen, Li, et al.
Publicado: (2019) -
Adverse Outcomes Associated With Interleukin-6 in Patients Recently Hospitalized for Heart Failure With Preserved Ejection Fraction
por: Mooney, Leanne, et al.
Publicado: (2023) -
Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction
por: Jackson, Alice M., et al.
Publicado: (2022) -
Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON‐HF trial
por: Chatur, Safia, et al.
Publicado: (2022)